Taís Cristina Unfer

Taís Cristina Unfer

Auto-generated profile, based on publicly available information

Taís Cristina Unfer

Universidade Federal de Sergipe

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2006 in Clinica Chimica Acta
Verified
Journal Article
Closed access
TUTaís C. Unfer
Taís C. Unfer
GCGreicy M.M. Conterato
Greicy M.M. Conterato
JSJoão C.N. da Silva
João C.N. da Silva
MDMarta M.M.F. Duarte
Marta M.M.F. Duarte
Tatiana EmanuelliTatiana Emanuelli
Tatiana Emanuelli

20 October 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FBFernanda Barbisan
Fernanda Barbisan
JMJéssica De Rosso Motta
Jéssica De Rosso Motta
ATAlexis Trott
Alexis Trott
VAVerônica Azzolin
Verônica Azzolin
EDEduardo Bortoluzzi Dornelles
Eduardo Bortoluzzi Dornelles
ICIvana Beatrice Beatrice Mânica Mânica Da Cruz
Ivana Beatrice Beatrice Mânica Mânica Da Cruz
Methotrexate (MTX) is a folic acid antagonist used in high doses as an anti-cancer treatment and in low doses for the treatment of some autoimmune diseases. MTX use has been linked to oxidative imbalance, which may cause multi-organ toxicities that can be attenuated by antioxidant supplementation. Despite the oxidative effect of MTX, the influence of antioxidant gene polymorphisms on MTX toxicity is not well studied. Therefore, we analyzed here whether a genetic imbalance of the manganese-dependent superoxide dismutase (SOD2) gene could have some impact on the MTX cytotoxic response. An in vitro study using human peripheral blood mononuclear cells (PBMCs) obtained from carriers with different Ala16Val-SOD2 genotypes (AA, VV and AV) was carried out, and the effect on cell viability and proliferation was analyzed, as well as the effect on oxidative, inflammatory and apoptotic markers. AA-PBMCs that present higher SOD2 efficiencies were more resistance to high MTX doses (10 and 100 µM) than were the VV and AV genotypes. Both lipoperoxidation and ROS levels increased significantly in PBMCs exposed to MTX independent of Ala16Val-SOD2 genotypes, whereas increased protein carbonylation was observed only in PBMCs from V allele carriers. The AA-PBMCs exposed to MTX showed decreasing SOD2 activity, but a concomitant up regulation of the SOD2 gene was observed. A significant increase in glutathione peroxidase (GPX) levels was observed in all PBMCs exposed to MTX. However, this effect was more intense in AA-PBMCs. Caspase-8 and -3 levels were increased in cells exposed to MTX, but the modulation of these genes, as well as that of the Bax and Bcl-2 genes involved in the apoptosis pathway, presented a modulation that was dependent on the SOD2 genotype. MTX at a concentration of 10 µM also increased inflammatory cytokines (IL-1β, IL-6, TNFα and Igγ) and decreased the level of IL-10 anti-inflammatory cytokine, independent of SOD2 genetic background. The results suggest that potential pharmacogenetic effect on the cytotoxic response to MTX due differential redox status of cells carriers different SOD2 genotypes.

12 November 2014 in Climacteric
Verified
Journal Article
Closed access
TUT. C. Unfer
T. C. Unfer
CFC. G. Figueiredo
C. G. Figueiredo
MZM. M. Zanchi
M. M. Zanchi
LML. H. Maurer
L. H. Maurer
DKD. M. Kemerich
D. M. Kemerich
Tatiana EmanuelliTatiana Emanuelli
Tatiana Emanuelli
This cross-sectional study aimed to evaluate the behavior of blood antioxidant enzymes (superoxide dismutase (SOD), catalase and glutathione peroxidase), plasma total antioxidant capacity and oxidative damage (lipid oxidation and protein carbonyl levels) and their relationship with the serum levels of steroid hormones in premenopausal and postmenopausal women without and with estrogen alone (ET) or estrogen plus progestin therapy (EPT). Blood was collected from four groups of subjects: premenopausal women (n = 24), postmenopausal women without hormone therapy (n = 31), postmenopausal women with ET (n = 12) and postmenopausal women with EPT (n = 16). The activities of the different SOD isoforms (CuZnSOD and MnSOD) and the plasma total antioxidant power were significantly higher in the postmenopausal women under EPT than in the postmenopausal women without hormone replacement therapy (HRT). Only CuZnSOD activity was increased in women receiving ET compared to the postmenopausal women without HRT. However, no differences were observed in the levels of lipid or protein oxidation or in the non-enzymatic plasma antioxidants (uric acid and albumin) among the groups. The duration of HRT and serum estrogen levels were positively correlated to the blood CuZnSOD activity and to plasma total antioxidant power, whereas the serum progesterone levels were positively correlated to CuZnSOD activity and negatively correlated to protein carbonyl groups. Interestingly, the total antioxidant power of plasma was positively correlated to CuZnSOD and glutathione peroxidase activities. We conclude that EPT increases blood MnSOD and CuZnSOD activity in postmenopausal women, leading to an increased plasma total antioxidant capacity. This finding may be relevant to the prevention of oxidative stress-related disorders in postmenopausal women.

1 December 2019 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
AAAudrei de Oliveira Alves
Audrei de Oliveira Alves
GWGrazielle Castagna Cezimbra Weis
Grazielle Castagna Cezimbra Weis
TUTaís Cristina Unfer
Taís Cristina Unfer
CACharles Elias Assmann
Charles Elias Assmann
FBFernanda Barbisan
Fernanda Barbisan
ICIvana Beatrice Beatrice Mânica Mânica Da Cruz
Ivana Beatrice Beatrice Mânica Mânica Da Cruz

1 January 2012 in Neotropical Ichthyology
Verified
Journal Article
Open access
PDF file
DFDaiane Ferreira
Daiane Ferreira
TUTaís Cristina Unfer
Taís Cristina Unfer
HRHélio Carlos Rocha
Hélio Carlos Rocha
LKLuiz Carlos Kreutz
Luiz Carlos Kreutz
GKGessi Koakoski
Gessi Koakoski
LBLeonardo José Gil Barcellos
Leonardo José Gil Barcellos
An experiment was conducted to evaluate the potential of honey, propolis, and bee pollen for the reversal of lipid peroxidation induced by tebuconazole (TEB) in South American catfish (Rhamdia quelen), in which the concentration of thiobarbituric acid reactive substances (TBARS), the activity of the antioxidant enzyme glutathione-S-transferase (GST) and the concentrations of non-enzymatic antioxidants, reduced glutathione (GSH), ascorbic acid, and non-protein thiols were assessed. Honey (0.125 g L-1) and bee pollen (0.05 g L-1) added to the water reverse the production of TBARS induced by TEB, while propolis demonstrated a pro-oxidant effect, inducing an increase in TBARS production. The data presented herein suggest that the addition of water to honey and bee pollen potentially protects against the oxidative stress caused by agrichemicals.

1 February 2006 in Food Additives & Contaminants
Verified
Journal Article
Closed access
JMJ. C. P. Mattos
J. C. P. Mattos
MHM. Hahn
M. Hahn
PAP. R. Augusti
P. R. Augusti
GCG. M. Conterato
G. M. Conterato
CFClarissa Frizzo
Clarissa Frizzo
Tatiana EmanuelliTatiana Emanuelli
Tatiana Emanuelli
The lead and calcium content of calcium supplements available in Brazil were determined by graphite furnace and flame atomic absorption spectrometry, respectively. Samples were microwave-digested in concentrated HNO3. Citric acid was used as a chemical modifier in the lead analysis. Supplements were classified into six categories: oyster industrialized (OI, n = 4), oyster prepared in pharmacy (OP, n = 3), refined industrialized (RI, n = 6), refined prepared in pharmacy (RP, n = 3), bone meal (B, n = 3), and dolomite (D, n = 4). Lead levels (µg g−1 of measured calcium) were higher in D products (2.33), followed by OI, RP, OP, and RI products (1.46, 1.32, 1.29, 0.75), while B products had levels lower than the limit of quantification (0.02 µg g−1 unit weight). Daily lead intake of eight supplements exceeded the limit of California, USA (1.5 µg g−1 calcium), but none exceeded the federal limit of USA (7.5 µg g−1 calcium) or the provisional tolerable lead intake by FAO/WHO (25 µg kg−1 per week).